Delphi-RAND consensus of the Spanish Society of Internal Medicine on the controversies in anticoagulant therapy and prophylaxis in medical diseases. INTROMBIN Project (Uncertainty in thromboprophylaxis in internal medicine)

被引:2
作者
Ruiz-Ruiz, F. [1 ]
Medrano, F. J. [2 ,3 ,4 ,5 ]
Navarro-Puerto, M. A. [6 ]
Rodriguez-Torres, P. [6 ]
Romero-Alonso, A. [5 ,6 ]
Santos-Lozano, J. M.
Alonso-Ortiz del Rio, C. [6 ]
Varela-Aguilar, J. M. [2 ,3 ,4 ,7 ]
Calderon, E. J. [2 ,3 ,4 ,5 ]
Marin-Leon, I. [2 ,3 ,4 ]
机构
[1] Hosp San Juan Dios Aljarafe, Serv Med Interna, Bormujos, Sevilla, Spain
[2] Hosp Univ Virgen Rocio, Serv Med Interna, Seville, Spain
[3] Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen Rocio, CSIC, Seville, Spain
[4] Ctr Invest Biomed Red Epidemiol & Salud Publ CIB, Seville, Spain
[5] Univ Seville, Dept Med, Seville, Spain
[6] Hosp Univ Virgen Valme, Serv Med Interna, Seville, Spain
[7] Inst Salud Carlos III, Distrito Sanitario Atenc Primaria Sevilla, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 07期
关键词
Venous thromboembolism disease; Prophylaxis; Risk; Anticoagulant therapy; Consensus; ED AMERICAN-COLLEGE; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM PROPHYLAXIS; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; PERIOPERATIVE MANAGEMENT; ORAL ANTICOAGULANTS; CANCER-PATIENTS; RISK; PREVENTION;
D O I
10.1016/j.rce.2018.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the opinion of internists on the management of anticoagulation and thromboembolism prophylaxis in complex clinical scenarios in which the risk-benefit ratio of surgery is narrow and to develop a consensus document on the use of drugs anticoagulant therapy in this patient group. To this end, we identified by consensus the clinical areas of greatest uncertainty, a survey was created with 20 scenarios laid out in 40 clinical questions, and we reviewed the specific literature. The survey was distributed among the internists of the Spanish Society of Internal Medicine (SEMI) and was completed by 290 of its members. The consensus process was implemented by changing the Delphi-RAND appropriateness method in an anonymous, double-round process that enabled an expert panel to identify the areas of agreement and uncertainty. In our case, we also added the survey results to the panel, a methodological innovation that helps provide additional information on the standard clinical practice. The result of the process is a set of 19 recommendations formulated by SEMI experts, which helps establish guidelines for action on anticoagulant therapy in complex scenarios (high risk or active haemorrhage, short life expectancy, coexistence of antiplatelet therapy or comorbidities such as kidney disease and liver disease), which are not uncommon in standard clinical practice. (C) 2018 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:358 / 371
页数:14
相关论文
共 48 条
[1]   Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer [J].
Akl, Elie A. ;
Labedi, Nawman ;
Terrenato, Irene ;
Barba, Maddalena ;
Sperati, Francesca ;
Sempos, Elena V. ;
Muti, Paola ;
Cook, Deborah ;
Schuenemann, Holger .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11)
[2]  
[Anonymous], GUIA PRETEMED 2007 P
[3]  
[Anonymous], OXMAN A GRADE WORKIN
[4]  
[Anonymous], MEDIT J HEMAT INFECT
[5]   Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease Report of the Guideline Development Subcommittee of the American Academy of Neurology [J].
Armstrong, Melissa J. ;
Gronseth, Gary ;
Anderson, David C. ;
Biller, Jose ;
Cucchiara, Brett ;
Dafer, Rima ;
Goldstein, Larry B. ;
Schneck, Michael ;
Messe, Steven R. .
NEUROLOGY, 2013, 80 (22) :2065-2069
[6]   New oral anticoagulants in patients with chronic kidney disease [J].
Belmar Vega, Lara ;
de Francisco, A. L. M. ;
Bada da Silva, Jairo ;
Galvan Espinoza, Luis ;
Fernandez Fresnedo, Gema .
NEFROLOGIA, 2017, 37 (03) :244-252
[7]   Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis [J].
Ben-Aharon, Irit ;
Stemmer, Salomon M. ;
Leibovici, Leonard ;
Shpilberg, Ofer ;
Sulkes, Aaron ;
Gafter-Gvili, Anat .
ACTA ONCOLOGICA, 2014, 53 (09) :1230-1237
[8]   Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery Results from the ETHOS registry [J].
Bergqvist, David ;
Arcelus, Juan I. ;
Felicissimo, Paulo .
THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) :280-287
[9]  
Calderon E, 2008, Farm Hosp, V32, P259
[10]   D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial [J].
Cohen, A. T. ;
Spiro, T. E. ;
Spyropoulos, A. C. ;
Desanctis, Y. H. ;
Homering, M. ;
Buller, H. R. ;
Haskell, L. ;
Hu, D. ;
Hull, R. ;
Mebazaa, A. ;
Merli, G. ;
Schellong, S. ;
Tapson, V. F. ;
Burton, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (04) :479-487